SurgLine International has entered into a three year agreement to provide its low cost surgical implants products to Castlegate Holdings.

Castlegate provides products, product financing and AR management to ambulatory surgical centers, rural hospitals, orthopedic and neurosurgical groups.

Castlegate said that it will use SurgLine’s products for approximately twenty surgical spine cases per month.

SurgLine CEO Thomas Toland said, "As we plan to expand our product line during the Agreement, the parties expect to increase monthly surgeries and the related revenues therein."

Castlegate Holdings managing director Brad Hoffman said, "Our provider clients are focused on ways to continue to provide and deliver the best quality care and products, but they are also trying to reduce cost by sourcing and using "best of breed" products with the most competitive pricing, and we think SurgLine is an excellent fit for this solution."